To investigate if BIM upregulation is also associated with ALK-rearranged NSCLC patient-derived cells, we used public RNA-seq data [35] to evaluate changes in BCL2L11 (BIM gene) mRNA in four EML4-ALK-positive patient-derived NSCLC cell lines. This evidence concerns the gene BCL2L11 and non-small cell lung carcinoma.